111 Inc
NASDAQ:YI
111 Inc
NASDAQ:YI
Price:
1.065 USD
3.4%
Market Closed
Updated:
Apr 30, 2024
Section:
Relative Value
The Relative Value of one
YI
stock under the Base Case scenario is
5.233
USD.
Compared to the current market price of 1.065 USD,
111 Inc
is
Undervalued by 80%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
YI
Relative Value
Base Case
5.233
USD
Undervaluation 80%
Valuation Multiples
Multiples Across Competitors
YI Competitors Multiples
111 Inc Competitors
111 Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
111 Inc
NASDAQ:YI
|
90m USD | 0 | -1.7 | -1 | -1 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
72.4B Zac | 0 | 0 | 0 | 0 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
28.4B Zac | 0 | 0 | 0 | 0 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
15.5B USD | 0.1 | -2.6 | 5.3 | 11.8 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
44.1B BRL | 1.3 | 41.8 | 12.7 | 22.7 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
43.3B CNY | 1.9 | 30 | 21.1 | 21.1 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
922.7B JPY | 0.9 | 18.2 | 9 | 11.6 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
17.7B SAR | 2 | 19.8 | 11.2 | 18.4 | |
| MX |
|
Corporativo Fragua SAB de CV
BMV:FRAGUAB
|
74.3B MXN | 0.7 | 16.5 | 7.5 | 8.8 | |
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
570.3B JPY | 0.6 | 23.7 | 11.2 | 18 | |
| CN |
D
|
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
|
24.5B CNY | 1 | 19.1 | 14.6 | 14.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
